Oxaliplatin Phase II Trial in Association With 5FU and Folinic Acid in the Treatment of Advanced Unresectable or Metastatic Gastric Cancer.

Trial Profile

Oxaliplatin Phase II Trial in Association With 5FU and Folinic Acid in the Treatment of Advanced Unresectable or Metastatic Gastric Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Nov 2010

At a glance

  • Drugs Fluorouracil; Folinic acid; Oxaliplatin
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 08 Nov 2010 Actual end date (Jul 2006) added as reported by ClinicalTrials.gov.
    • 08 Nov 2010 Last checked against ClinicalTrials.gov.
    • 24 Aug 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top